Dr Cheng-Yi Kuo is the Vice General Manager of UWELL Biophama, Taiwan, and is involved with new product development/R&D, clinical development of cell & gene therapy and business development and corporate strategy. Dr Kuo has extensive experience in biological product development, quality requirements and regulatory approval and clinical trial research. Dr Kuo also worked in research and development as a drug and gene delivery scientist and managed a group of scientists in that area. He has 20 years of experience in biologics development, biological product life cycle, quality and regulatory affairs. He is also an assistant professor at National Defense Medical Center and Chung Yuan Christian University. He received his PhD in Pharmaceutical Biology from Monash University.